Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) (neuroscience | USA)

National Institutes of Health (NIH)

The Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) from the National Institutes of Health (NIH), through the National Institute of Neurological Disorders and Stroke (NINDS), supports the transition of NIH-trained neurologist- and neurosurgeon-scientists from the NINDS intramural program to independent academic faculty positions.

Applicants may gain experience in a clinical trial led by a mentor but may not lead an independent clinical trial. Applications are open to clinically licensed neurologists and neurosurgeons in the NINDS intramural program who hold a clinical doctorate (MD, DO or equivalent) and are within 4 years of completing residency or clinical fellowship (5 years for resubmissions).

Candidates must be US citizens, non-citizen nationals or permanent residents, must still be in the career development phase, and must not have held an NIH career development award or served as PD/PI on an NIH research grant. NINDS applies for the mentored intramural phase on the candidate’s behalf; US academic institutions host the extramural phase.

During the extramural phase, NINDS contributes up to 125,000 USD per year toward salary and 50,000 USD per year toward research development costs; during the intramural phase, NINDS contributes 25,000 USD per year toward research career development costs. The award lasts up to 5 years, with up to 2 years in the intramural phase and the remainder at an extramural institution.

Opportunity number: PAR-25-215

The next applications are due on February 12, 2027, with further cycles through the final due date of November 12, 2027.